In May 2016, the Canadian Institutes of Health research (CIHR) and the International Development Research Centre (IDRC) launched a funding opportunity on Zika virus, in response to viral outbreaks in both the Americas and the Caribbean.
CIHR and IDRC are pleased to announce the first round of grant recipients from this funding opportunity. Three collaborative teams will be supported under the initiative, which represents a total investment of CAD$3M over three years (2016-2019).
The CIHR-IDRC Canada-Latin America and Caribbean Zika Virus Research Program aligns with parameters set out by the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R). The funding opportunity is intended to support research investment in areas where new knowledge on Zika virus will help develop diagnostics for infection, understand the pathology of the virus and, ultimately, prevent its transmission and morbidity.
Teams applying for funding under this program were required to include both researchers based in Canada and those based in low- and middle-income countries in Latin America and the Caribbean (LAC).
Funding recipients for the CIHR-IDRC Canada-Latin America and Caribbean Zika Virus Research Program
Development and Deployment of Low Cost, Paper-based Zika Diagnostics. Keith I. Pardee, University of Toronto, Canada; Jaime E. Castellanos, Universidad El Bosque, Colombia; Varsovia E. Cevallos, Public Health of Ecuador, Ecuador; Lindomar Pena, Instituto Oswaldo Cruz – FIOCRUZ, Brazil (Principal Investigators); Constancia F. Ayres, Instituto Oswaldo Cruz – FIOCRUZ, Brazil; Eduardo T. Jurado, Public Health of Ecuador, Ecuador; Aaron R. Wheeler, University of Toronto, Canada (Co-Investigators).
Molecular basis for Zika virus pathogenesis. Tom C. Hobman, University of Alberta, Canada; Ana de Filippis Instituto Oswaldo Cruz – FIOCRUZ, Brazil (Principal Investigators); Lori D. Frappier University of Toronto, Canada (Co-Investigators).
Assessing ZIKV transmission dynamics and mitigation strategies. A multidisciplinary approach. Beate H. Sander, University of Toronto, Canada; Eduardo M. Espinel, University of Manabi, Ecuador; Camila Gonzalez, Universidad de los Andes (UNIANDES), Colombia; Manisha A. Kulkarni, University of Ottawa, Canada; Marcos M. Miretti, CONICET – Universidad Nacional de Misiones, Argentina; Jianhong Wu, York University, Canada (Principal Investigators); Varsovia E. Cevallos, Public Health of Ecuador, Ecuador; Julian Ferreras, ONICET – Universidad Nacional de Misiones, Argentina; Jonathan B. Gubbay, Ontario Agency for Health Protection and Promotion, Canada; Thomas Jaenisch, Heidelberg University Hospital, Germany; Carlos J. Jimenez, Universidad San Francisco de Quito, Ecuador; Kamran Khan, Li Ka Shing Knowledge Institute, Canada; Mark B. Loeb, McMaster University, Canada; Eduardo Massad, Vector studies project. University of Sao Paulo, Brazil; Shaun K. Morris, Hospital for Sick Children, Canada; Kellie E. Murphy, Mount Sinai Hospital, Canada; Nicholas H. Ogden, Public Health Agency of Canada; Mark W. Rowland, London School of Hygiene and Tropical Medicine; Nubia C. Tovar Acero, University of Sinu, Colombia; William Wai Lun Wong, University of Waterloo, Canada; Horacio F. Zelaya, Posadas City Council, Argentina (Co-Investigators).